During the past decade, Hospital Virgen del Camino conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Virgen del Camino" #1 sponsor was "PETHEMA Foundation" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored, "Clinica Universidad de Navarra, Universidad de Navarra" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Virgen del Camino" #1 collaborator was "Celgene" with 1 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 1 trials as a collaborator, "Instituto de Investigación Hospital Universitario La Paz" with 1 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator and "Merck, S.L., Spain" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Virgen del Camino" are "Multiple Myeloma" (3 trials), "Infant, Small for Gestational Age" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Allergic Rhinitis Due to Dust Mite" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Hospital Virgen del Camino" in a lesser frequency.

Most popular intervention types in "Hospital Virgen del Camino" are "Drug" (12 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Prednisone" (3 trials), "Cyclophosphamide" (2 trials), "Cytarabine" (2 trials), "Daunorubicin" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Virgen del Camino" are 16 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Virgen del Camino". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Hospital Virgen del Camino, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Virgen del Camino, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".